BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Staging
3 results:

  • 1. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Ferrokinetics in 1-dimensional whole-body profiles in hematologic diseases].
    Schober O; Häbel U; Diehl V; Creutzig H; Knoop B; Müller S; Hundeshagen H
    Nuklearmedizin; 1983 Feb; 22(1):1-19. PubMed ID: 6408612
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bone marrow biopsy in chronic lymphocytic leukaemia: a study of 208 cases.
    Montserrat E; Rozman C
    Haematologia (Budap); 1983; 16(1-4):73-9. PubMed ID: 6679490
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.